GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » Other Long-Term Liabilities

Novonesis (Novozymes) B (OCSE:NSIS B) Other Long-Term Liabilities : kr10,348 Mil (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B Other Long-Term Liabilities?

Novonesis (Novozymes) B's other long-term liabilities for the quarter that ended in Mar. 2025 was kr10,348 Mil.

Novonesis (Novozymes) B's quarterly other long-term liabilities increased from Jun. 2024 (kr11,524 Mil) to Dec. 2024 (kr21,861 Mil) but then declined from Dec. 2024 (kr21,861 Mil) to Mar. 2025 (kr10,348 Mil).

Novonesis (Novozymes) B's annual other long-term liabilities increased from Dec. 2022 (kr2,881 Mil) to Dec. 2023 (kr6,791 Mil) and increased from Dec. 2023 (kr6,791 Mil) to Dec. 2024 (kr21,861 Mil).


Novonesis (Novozymes) B Other Long-Term Liabilities Historical Data

The historical data trend for Novonesis (Novozymes) B's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Other Long-Term Liabilities Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,474.65 2,850.58 2,880.59 6,790.83 21,860.75

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,790.83 - 11,524.40 21,860.75 10,348.20

Novonesis (Novozymes) B Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Novonesis (Novozymes) B Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines